Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shanghai
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Humanwell Healthcare Group Co Ltd

+ Add to Watchlist

600079:CH

29.720 CNY 0.430 1.47%

As of 02:05:34 ET on 03/05/2015.

Snapshot for Humanwell Healthcare Group Co Ltd (600079)

Open: 29.200 Day's Range: 29.000 - 29.990 Volume: 11,291,718
Previous Close: 29.290 52wk Range: 23.510 - 31.490 1-Yr Rtn: +26.15%

Stock Chart for 600079

No chart data available.
  • 600079:CH 29.700
  • 1D
  • 1M
  • 1Y
29.290
Interactive 600079 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 600079

Current P/E Ratio (ttm) 35.7857
Estimated P/E(12/2014) 33.4308
Relative P/E vs. SHASHR 2.2645
Earnings Per Share (CNY) (ttm) 0.8305
Est. EPS (CNY) (12/2014) 0.8890
Est. PEG Ratio -
Market Cap (M CNY) 15,715.26
Shares Outstanding (M) 528.78
30 Day Average Volume 9,566,033
Price/Book (mrq) 3.4064
Price/Sale (ttm) 2.3441
Dividend Indicated Gross Yield 0.40%
Cash Dividend (CNY) 0.1200
Dividend Ex-Date 07/07/2014
5 Year Dividend Growth 23.36%
Next Earnings Announcement 03/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 600079

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 600079

Humanwell Healthcare (Group) Co., Ltd specializes in the R&D and sales of pharmaceuticals, biotechnology, and chemical products, in addition to the import and export of goods and technology. The company, through its subsidiaries, also operate in real estate development and sales, industrial investment and management, and education projects.

Wang XuehaiChairmanLi JiePresident
Wu YajunVP/ControllerXu HuabinVice President
More Company Profile & Key Executives for 600079

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil